EPISODE · May 5, 2026 · 1 MIN
Privium Invests $5M in Denali Therapeutics
from The Daily News Now! Business
Privium Fund Management invests $5.07M in Denali Therapeutics, acquiring a 1% stake in the brain-penetrating drug tech company. Denali, focusing on neurodegenerative diseases, recently received FDA approval for Avlayah, its first drug targeting Hunter syndrome symptoms. Shares closed at $18.67, up 18.32% year-to-date, but lagging the S&P 500. Priviums investment, behind Tesla and Shopify, is a high-risk, high-reward bet on Denalis expanding pipeline. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/774079f465405bb4
NOW PLAYING
Privium Invests $5M in Denali Therapeutics
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m